Zentalis Pharmaceuticals
ZNTL
ZNTL
102 hedge funds and large institutions have $102M invested in Zentalis Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 30 increasing their positions, 28 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5.23% more ownership
Funds ownership: 56.18% → 61.41% (+5.2%)
7% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 28
Holders
102
Holding in Top 10
1
Calls
$971K
Puts
$138K
Top Buyers
| 1 | +$9.38M | |
| 2 | +$3.84M | |
| 3 | +$1.6M | |
| 4 |
Millennium Management
New York
|
+$1.59M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.45M |
Top Sellers
| 1 | -$2.44M | |
| 2 | -$1.42M | |
| 3 | -$1.34M | |
| 4 |
Morgan Stanley
New York
|
-$1.17M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$683K |
